Roth Capital raised the firm’s price target on Calix (CALX) to $85 from $69 and keeps a Buy rating on the shares following what the firm calls “another solid beat and raise” report for Q3. Broad-based demand and RPO strength is expected to continue into 2026, in part enabled by the imminently commercializing third gen platform, says the analyst, who sees Calix entering “a potential phase of multiple expansion.”
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CALX:
